Pfizer's Options Frenzy: What You Need to Know
Portfolio Pulse from Benzinga Insights
Investors have taken a predominantly bearish stance on Pfizer (NYSE:PFE) as observed through recent options trading activity. Benzinga's options scanner detected 10 significant trades, with 90% of the sentiment being bearish. The trades suggest a targeted price range of $20.0 to $30.0 for Pfizer over the next few months. Analysts have mixed ratings, with price targets ranging from $29 to $36.
May 30, 2024 | 6:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Recent options trading activity shows a predominantly bearish sentiment towards Pfizer, with 90% of the trades being bearish. The targeted price range is between $20.0 and $30.0. Analysts have mixed ratings, with price targets ranging from $29 to $36.
The high volume of bearish options trades suggests that investors are expecting a decline in Pfizer's stock price. The mixed analyst ratings add to the uncertainty, but the overall sentiment leans negative.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100